Core Viewpoint - Fluor Corporation (NYSE: FLR) is facing allegations of issuing materially false and misleading statements regarding its financial performance and project costs during the class period from February 18, 2025, to July 31, 2025 [1]. Allegations - The complaint claims that Fluor's costs for infrastructure projects, including Gordie Howe, I-635/LBJ, and I-35, were increasing due to subcontractor design errors, price hikes, and scheduling delays [1]. - It is alleged that these issues, along with reduced capital spending from customers and hesitance due to economic uncertainty, were significantly impacting Fluor's business and financial results [1]. - The financial guidance provided by Fluor for FY 2025 is described as unreliable and unrealistic, with an overstated effectiveness of the company's risk mitigation strategy and an understated impact of economic uncertainty [1]. - Consequently, the public statements made by Fluor were deemed materially false and misleading throughout the relevant period [1]. Next Steps for Shareholders - Shareholders who purchased FLR shares during the specified timeframe are encouraged to register for the class action, with a deadline set for November 14, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [2].

Core Points - The Gross Law Firm has issued a notice to shareholders of Nutex Health Inc. regarding a class action lawsuit related to misleading statements and financial reporting issues [1][2] - The class period for the lawsuit is from August 8, 2024, to August 14, 2025, during which the company allegedly engaged in fraudulent activities through a third-party vendor, HaloMD [2] - Shareholders are encouraged to register for the class action by the deadline of October 21, 2025, to potentially become lead plaintiffs [3] Allegations Summary - The complaint alleges that Nutex Health Inc. made materially false and misleading statements, including the fraudulent conduct of HaloMD in defrauding insurance companies [2] - It is claimed that revenues from HaloMD's engagement were unsustainable due to the fraudulent nature of the activities [2] - The company reportedly overstated its ability to remediate weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [2] Next Steps for Shareholders - Shareholders who purchased shares during the specified class period should register to receive updates and monitor the case's progress [3] - There is no cost or obligation for shareholders to participate in the class action [3] Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4] - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated stock prices [4]

Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Company Ratings - **Huntsman Corporation (NYSE:HUN)**: - Dividend Yield: 12.17% - Mizuho analyst John Roberts maintained an Underperform rating and reduced the price target from $9 to $8 [7] - Jefferies analyst Laurance Alexander maintained a Buy rating and lowered the price target from $15 to $14 [7] - Upcoming conference call on Nov. 7 to discuss Q3 2025 results [7] - **Dow Inc (NYSE:DOW)**: - Dividend Yield: 6.40% - Mizuho analyst John Roberts maintained a Neutral rating and cut the price target from $30 to $26 [7] - Jefferies analyst Laurence Alexander maintained a Hold rating and reduced the price target from $28 to $23 [7] - Declared a quarterly dividend of 35 cents per share on Oct. 9 [7] - **Sonoco Products Co (NYSE:SON)**: - Dividend Yield: 5.30% - Wells Fargo analyst Gabe Hajde maintained an Overweight rating and lowered the price target from $55 to $50 [7] - Citigroup analyst Anthony Pettinari maintained a Buy rating and cut the price target from $56 to $55 [7] - Recently agreed to sell Temperature-Assured Packaging business to Arsenal Capital Partners [7]

Core Insights - Investors are increasingly turning to dividend-yielding stocks during market turbulence and uncertainty, as these companies typically have high free cash flows and offer substantial dividend payouts [1] Company Summaries Huntsman Corporation (NYSE:HUN) - Dividend Yield: 12.17% - Mizuho analyst John Roberts maintained an Underperform rating and reduced the price target from $9 to $8 on October 3, 2025, with an accuracy rate of 70% [7] - Jefferies analyst Laurance Alexander maintained a Buy rating but lowered the price target from $15 to $14 on September 10, 2025, with an accuracy rate of 74% [7] - Upcoming event: Huntsman will hold a conference call on November 7 to discuss its Q3 2025 financial results [7] Dow Inc (NYSE:DOW) - Dividend Yield: 6.40% - Mizuho analyst John Roberts maintained a Neutral rating and cut the price target from $30 to $26 on October 3, 2025, with an accuracy rate of 70% [7] - Jefferies analyst Laurence Alexander maintained a Hold rating and reduced the price target from $28 to $23 on September 8, 2025, with an accuracy rate of 74% [7] - Recent news: Dow declared a quarterly dividend of 35 cents per share on October 9 [7] Sonoco Products Co (NYSE:SON) - Dividend Yield: 5.30% - Wells Fargo analyst Gabe Hajde maintained an Overweight rating and lowered the price target from $55 to $50 on October 15, 2025, with an accuracy rate of 77% [7] - Citigroup analyst Anthony Pettinari maintained a Buy rating and cut the price target from $56 to $55 on September 29, 2025, with an accuracy rate of 74% [7] - Recent news: Sonoco agreed to sell its Temperature-Assured Packaging business to Arsenal Capital Partners on September 8 [7]

Summary of Global Chemicals Conference Call Industry Overview - The global chemicals cycle is weakening beyond prior expectations, with caution heightened by the Braskem situation, indicating a need for additional due diligence and/or a higher risk premium [1][3] - The European chemical sector is losing competitiveness due to high energy costs, strict carbon policies, and persistent overcapacity, leading to plant closures and asset sales [3][16] - China's aggressive capacity expansion has created a global oversupply in chemicals, particularly in TiO2, PVC, ethylene, and polyethylene, driving down prices [6][8] Key Points European Chemical Sector - BASF's proactive restructuring and noncore asset sales are helping maintain its low-A ratings despite weak upstream margins [3] - Ineos Group Holdings and Ineos Quattro are experiencing rating downgrades due to operational weaknesses and inflated leverage [3] - The European chemical industry has seen output decline by over 50% since 2003, with natural gas prices in Europe being 3-4 times higher than in the US [16][22] - The EU's REACH regulation and the EU Emissions Trading System (EU ETS) are increasing compliance costs for European firms, further eroding competitiveness [21][22] Chinese Market Dynamics - China's share of global chemical capacity has surged from around 15% to nearly 50% over two decades, leading to a persistent supply-demand imbalance [8] - CMA projects that China will add significant ethylene capacity, exceeding current total capacity in Europe, exacerbating global oversupply [9][36] Demand Challenges - The automotive and construction sectors, critical end markets for chemical producers, are experiencing prolonged softness, negatively impacting chemical demand [12] - In the US, existing home sales have slowed significantly, and the European construction sector has contracted due to high interest rates and labor shortages [12] Braskem Case Study - Braskem's credit deterioration highlights risks in oversupplied chains and reliance on high-cost naphtha feedstock, with net leverage exceeding 10x [52][53] - The company has faced rapid downgrades, reflecting how quickly credit can deteriorate in a prolonged industry downturn [54][55] Latin American Chemical Credits - Latin American chemical credits face heightened risks from oversupply and weak spreads, with downgrades likely if earnings disappoint [6][59] - Orbia and Alpek have been downgraded to Market Weight, while Braskem remains Underweight due to deteriorating PVC fundamentals [69][71] North American Chemical Producers - US investment-grade chemical producers like DOW and LYB are seeing EBITDA collapse, with estimates for 2025 now 50% lower than a year prior [72][73] - The US high-yield chemical index has widened, underperforming the broader high-yield index due to exposure to chains affected by Chinese capacity issues [76] Trade Recommendations - Buy BASF 4.25% 2032s and sell Orbia 2030s due to heightened fallen angel risk [8][62] - Switch into SGLSJ 2029s from SASOL 2028s as part of a strategy to optimize exposure [8] Conclusion - The global chemicals sector is facing significant challenges from oversupply, weak demand, and regulatory pressures, particularly in Europe and North America. The situation is exacerbated by China's aggressive capacity expansion and the ongoing credit deterioration of key players like Braskem. Investors are advised to exercise caution and consider strategic trades to mitigate risks.

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the October 28, 2025, deadline to become lead plaintiffs in a class action lawsuit due to alleged misleading statements by the company [1][2]. Group 1: Class Action Details - The class action lawsuit claims that Dow Inc. made false and misleading statements regarding its ability to handle macroeconomic challenges and maintain financial flexibility for dividends [4]. - The lawsuit alleges that Dow understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business and financial condition [4]. - Investors are encouraged to join the class action without any out-of-pocket fees through a contingency fee arrangement [1][2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [3].

Core Insights - The strength of the U.S. Dollar significantly impacts various asset classes, including stocks, bonds, and commodities, making it a critical factor for investors to consider in 2025 [1][2] Group 1: Hedge Fund Activity - Hedge funds have recently reversed their short positions on the U.S. Dollar, leading to a 3% rally in the Dollar Index this month, driven by rising tariffs, geopolitical uncertainty, and increasing gold prices [2][3] Group 2: Company Opportunities - U.S. companies with substantial international exposure, such as Airbnb, Home Depot, and Dow, are positioned to benefit from the stronger Dollar through margin expansion, demand recovery, and improved free cash flow [3][4] Group 3: Airbnb Analysis - Airbnb generates over half of its revenue from non-U.S. listings, making it sensitive to international travel dynamics and currency fluctuations, with a current stock price of $125.91 and a 12-month price forecast of $141.81, indicating a 12.63% upside [4][7] - A stronger Dollar is expected to boost international travel, benefiting Airbnb by encouraging more Americans to travel abroad and making travel services more attractive to U.S. travelers [5] Group 4: Home Depot Analysis - Home Depot stands to gain from a stronger Dollar as it reduces the cost of goods sold, potentially leading to margin expansion and improved gross profit margins, with a current stock price of $391.79 and a 12-month price forecast of $435.42, indicating an 11.14% upside [8][9] - Despite a recent decline of 10.4% in its stock price, analysts maintain a positive outlook, suggesting that the bottom may be near [10] Group 5: Dow Analysis - Dow's stock is currently at 40% of its 52-week high, with a consensus price target of $29.63, implying a 36% upside, as a stronger Dollar could lower input costs and improve free cash flow conversion [11][12]

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1][2]. Company Performance - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and demand forecasting for its products [2]. - On July 30, 2025, Tronox reported a significant decline in TiO2 sales, attributing it to a "softer than anticipated coatings season and heightened competitive dynamics" [2]. - Following the disappointing financial results, Tronox lowered its full-year revenue guidance and reduced its dividend by 60% [2]. Stock Market Reaction - Tronox's stock price fell dramatically from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in just one day [2]. Legal Proceedings - Investors who suffered losses during the relevant time frame have until November 3, 2025, to request to be appointed as lead plaintiff in the class action [3]. - Participation in the lawsuit does not require investors to incur any out-of-pocket costs or fees [3]. Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4].

Core Viewpoint - Dow Inc. is recognized as one of the best dividend stocks to buy despite a significant decline in its stock price, which has dropped over 44% in 2025 [1]. Group 1: Stock Performance and Analyst Ratings - RBC Capital has lowered Dow Inc.'s price target from $26 to $24 while maintaining a Sector Perform rating, reflecting a cautious outlook ahead of the third-quarter earnings for chemical companies [2]. - The stock has faced challenges due to soft demand across the industry, particularly in the Building and Construction sector, which has been subdued [3]. Group 2: Dividend and Income Appeal - Despite reducing its dividend earlier this year, Dow Inc. has a strong history of 457 consecutive dividend payments and currently offers a quarterly dividend of $0.35 per share, resulting in a dividend yield of 6.39% as of October 16 [4]. Group 3: Company Positioning - Dow Inc. is a leading materials science company, providing innovative solutions in high-growth sectors such as packaging, infrastructure, mobility, and consumer applications [5].

Core Insights - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving F5, Inc., focusing on whether F5 and its executives made false or misleading statements or failed to disclose material information to investors [1][2] Company Overview - F5, Inc. provides multi-cloud application security and delivery solutions [2] Recent Developments - On October 15, 2025, F5 disclosed that a highly sophisticated nation-state threat actor gained unauthorized access to certain F5 systems, maintaining long-term access to systems including the BIG-IP product development environment [3] - The investigation revealed that certain files were exfiltrated, including portions of the BIG-IP source code and information about undisclosed vulnerabilities [3] - Following this revelation, the price of F5 shares experienced a decline [3]